Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Testosterone Undecanoate in Hypogonadal Men
NCT01403116Phase 3Completed
- Sponsor
- Clarus Therapeutics
- Start
- Jul 2011
- Primary completion
- Sep 2013
- Modality
- Hormone, Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of testosterone undecanoate in male hypogonadism, sponsored by Clarus Therapeutics. Started Jul 2011; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
male hypogonadism
Beyond the preview
Go deeper on NCT01403116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403116.